ESCAPE Migraine Trial

Stopped early · Phase 3

Conditions studied: Migraine Disorders, Heart Septal Defects, Atrial

In brief

The purpose of this two arm controlled double-blind study is to determine the safety and effectiveness of PFO closure (closing a hole in the wall of the heart) in reducing the frequency of migraine headaches, in patients who experience migraine headaches and have a PFO, compared to medical therapy alone.

Key facts

Study ID
NCT00267371
Run by
Abbott Medical Devices
People needed
168
Starts
2005-11-01
Expected to finish
2012-03-01
Last updated by the study team
2019-02-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.